CRYPTOCOCCUS NEOFORMANS - ANVISA Registration 80254180243

Access comprehensive regulatory information for CRYPTOCOCCUS NEOFORMANS in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80254180243 and manufactured by manufacturer not specified. The registration is held by PHADIA DIAGNOSTICOS LTDA with validity until Jan 30, 2026.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including BIOSYNEX S.A., ALAMAR TECNO CIENTÍFICA LTDA, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
80254180243
2 Related Devices
Registration Details
ANVISA Registration Number: 80254180243
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

CRYPTOCOCCUS ANTIGEN LATEX TEST
Risk Class III

Registration Details

80254180243

25351151378201702

04930429000139

Company Information

Dates and Status

Apr 24, 2017

30/01/2026

09/18/2025 19:00:01

CRYPTOCOCCUS ANTIGEN LATEX TEST
Risk Class III

Registration Details

80254180243

25351151378201702

04930429000139

Company Information

REMEL INC
United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

Apr 24, 2017

30/01/2026

09/18/2025 19:00:01